Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease

References

• Chen CY, Lu CL, Huang YS, et al. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing. 1998;27(4):437–441. doi:10.1093/ageing/27.4.437
   PubMedGoogle Scholar
• Liu CM, Tung TH, Chou P, et al. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin general hospital. World J Gastroenterol. 2006;12(8):1281–1286. doi:10.3748/wjg.v12.i8.1281
   PubMedGoogle Scholar
• Chen YC, Chiou C, Lin MN, Lin CL. The prevalence and risk factors for gallstone disease in taiwanese vegetarians. PLoS One. 2014;9(12):e115145. doi:10.1371/journal.pone.0115145
   PubMedGoogle Scholar
• Lai SW, Ng KC. Risk factors for gallstone disease in a hospital-based study. South Med J. 2002;95(12):1419–1423. doi:10.1097/00007611-200295120-00013
   PubMedGoogle Scholar
• Lu SN, Chang WY, Wang LY, et al. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol. 1990;12(5):542–546. doi:10.1097/00004836-199010000-00011
   PubMedGoogle Scholar
• Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172–187. doi:10.5009/gnl.2012.6.2.172
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology. 2011;140(2):508–516. doi:10.1053/j.gastro.2010.10.060
   PubMedGoogle Scholar
• He W, Goodkind D, Kowal PR. An aging world: 2015. 2016.
   Google Scholar
• Nassar Y, Richter S. Management of complicated gallstones in the elderly: comparing surgical and non-surgical treatment options. Gastroenterol Rep. 2019;7(3):205–211. doi:10.1093/gastro/goy046
   Google Scholar
• Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol. 2008;67(2):124–132. doi:10.1016/j.critrevonc.2008.01.013
   PubMed Web of Science ®Google Scholar
• Sandblom G, Videhult P, Crona Guterstam Y, Svenner A, Sadr-Azodi O. Mortality after a cholecystectomy: a population-based study. HPB (Oxford). 2015;17(3):239–243. doi:10.1111/hpb.12356
   PubMed Web of Science ®Google Scholar
• Buchner AM, Sonnenberg A. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. Am J Gastroenterol. 2002;97(4):905–909. doi:10.1111/j.1572-0241.2002.05607.x
   PubMedGoogle Scholar
• Moro PL, Checkley W, Gilman RH, et al. Gallstone disease in high-altitude Peruvian rural populations. Am J Gastroenterol. 1999;94(1):153–158. doi:10.1111/j.1572-0241.1999.00787.x
   PubMedGoogle Scholar
• Kratzer W, Kächele V, Mason RA, et al. Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm gallstone study. Scand J Gastroenterol. 1997;32(9):953–958. doi:10.3109/00365529709011208
   PubMed Web of Science ®Google Scholar
• Ata N, Kucukazman M, Yavuz B, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25(5):274–276. doi:10.1155/2011/356761
   PubMedGoogle Scholar
• Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol. 2006;21(11):1737–1743. doi:10.1111/j.1440-1746.2006.04381.x
   PubMedGoogle Scholar
• Chang Y, Noh YH, Suh BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: a cohort study. J Clin Med. 2018;7(11):458. doi:10.3390/jcm7110458
   PubMed Web of Science ®Google Scholar
• Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012;47(2):197–203. doi:10.3109/00365521.2011.643481
   PubMed Web of Science ®Google Scholar
• Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci. 2011;48(3):97–113. doi:10.3109/10408363.2011.596521
   PubMed Web of Science ®Google Scholar
• de Alwis NMW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48:S104–S112. doi:10.1016/j.jhep.2008.01.009
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Lonardo A, Mussi C, et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014;20(39):14185–14204. doi:10.3748/wjg.v20.i39.14185
   PubMed Web of Science ®Google Scholar
• Frith J, Jones D, Newton JL. Chronic liver disease in an ageing population. Age Ageing. 2009;38(1):11–18. doi:10.1093/ageing/afn242
   PubMedGoogle Scholar
• Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol. 1999;5(4):301–304. doi:10.3748/wjg.v5.i4.301
   PubMedGoogle Scholar
• Nalbantoglu IL, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(27):9026–9037. doi:10.3748/wjg.v20.i27.9026
   PubMed Web of Science ®Google Scholar
• Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc. 2015;90(9):1233–1246. doi:10.1016/j.mayocp.2015.06.013
   PubMed Web of Science ®Google Scholar
• Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21(9):1023–1032 (). doi:10.7863/jum.2002.21.9.1023
   PubMedGoogle Scholar
• Jørgensen T. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut. 1989;30(4):528–534. doi:10.1136/gut.30.4.528
   PubMedGoogle Scholar
• Lee YC, Wu JS, Yang YC, Chang CS, Lu FH, Chang CJ. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scand J Gastroenterol. 2014;49(8):1001–1006. doi:10.3109/00365521.2014.920912
   PubMed Web of Science ®Google Scholar
• Cariati A. Gallstone classification in western countries. Indian J Surg. 2015;77(Suppl 2):376–380. doi:10.1007/s12262-013-0847-y
   PubMedGoogle Scholar
• Trotman BW. Pigment gallstone disease. Gastroenterol Clin North Am. 1991;20(1):111–126.
   PubMed Web of Science ®Google Scholar
• Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J. 2001;77(906):221–229. doi:10.1136/pmj.77.906.221
   PubMedGoogle Scholar
• Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ. Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995;40(9):1963–1973. doi:10.1007/BF02208665
   PubMedGoogle Scholar
• Jørgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126(5):912–921. doi:10.1093/oxfordjournals.aje.a114728
   PubMed Web of Science ®Google Scholar
• Atamanalp SS, Keles MS, Atamanalp RS, Acemoglu H, Laloglu E. The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration. Pak J Med Sci. 2013;29(1):187–190. doi:10.12669/pjms.291.2798
   PubMed Web of Science ®Google Scholar
• Stringer MD, Fraser S, Gordon KC, Sharples K, Windsor JA. Gallstones in New Zealand: composition, risk factors and ethnic differences. ANZ J Surg. 2013;83(7–8):575–580. doi:10.1111/j.1445-2197.2012.06234.x
   PubMedGoogle Scholar
• Novacek G. Gender and gallstone disease. Wien Med Wochenschr. 2006;156(19–20):527–533. doi:10.1007/s10354-006-0346-x
   PubMedGoogle Scholar
• Jensen KH, Jørgensen T. Incidence of gallstones in a Danish population. Gastroenterology. 1991;100(3):790–794. doi:10.1016/0016-5085(91)80027-7
   PubMed Web of Science ®Google Scholar
• Yoo E-H, Lee S-Y. The prevalence and risk factors for gallstone disease. Clin Chem Lab Med. 2009;47:795–807. doi:10.1515/CCLM.2009.194
   PubMedGoogle Scholar
• Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11(11):1653–1657. doi:10.3748/wjg.v11.i11.1653
   PubMedGoogle Scholar
• Hsu HY, Huang CY, Hwang LC. Sex difference of the predictive value of BMI, waist circumference and percentage body fat mass for gallstone disease. Br J Nutr. 2019;121(8):955–960. doi:10.1017/S000711451900028X
   PubMed Web of Science ®Google Scholar
• Aganović I, Dušek T. Pathophysiology of metabolic syndrome. Ejifcc. 2007;18(1):3–6.
   PubMedGoogle Scholar
• Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J. 1984;289(6444):521–525. doi:10.1136/bmj.289.6444.521
   PubMedGoogle Scholar
• de Leon MP, Ferenderes R, Carulli N. Bile lipid composition and bile acid pool size in diabetes. Am J Dig Dis. 1978;23(8):710–716. doi:10.1007/BF01072357
   PubMedGoogle Scholar
• Biddinger SB, Haas JT, Yu BB, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008;14(7):778–782. doi:10.1038/nm1785
   PubMed Web of Science ®Google Scholar
• Andreotti G, Chen J, Gao YT, et al. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer. 2008;122(10):2322–2329. doi:10.1002/ijc.23307
   PubMed Web of Science ®Google Scholar
• Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology. 1990;99(3):843–849. doi:10.1016/0016-5085(90)90978-A
   PubMedGoogle Scholar